For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common?

PHILADELPHIA - Century Therapeutics, Inc. (NASDAQ: IPSC), a biotechnology firm with a market capitalization of $77.32 million ...

Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...

A WOMAN from Salisbury had her head shaved to raise money for charity after being diagnosed with MS. Hannah Schmidt, 35, is a mum of three boys and the family lives in Salisbury. In December 2020, she ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

Additionally, Arvinas has initiated a Phase 1 trial of the PROTAC LRRK2 degrader ARV-102 for Parkinson's disease and expects to present data from multiple ... patients with B-cell lymphomas.” ...

the proportion of patients with improvement in EDSS was very similar to that reported in the randomised controlled Multiple Sclerosis International Stem Cell Transplant trial.12 The comprehensive ...

The company expects the last relapsing-remitting multiple sclerosis patient to complete the trial by the third quarter of this year. Credit: illustrissima ...

Embryos: The use of stem cells is controversial. Ethical reasons have therefore limited their use, although more research is being done to explore the future potential of this treatment. National ...